These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8730222)

  • 1. Buspirone in the treatment of alcohol dependence: a placebo-controlled trial.
    Malec E; Malec T; Gagné MA; Dongier M
    Alcohol Clin Exp Res; 1996 Apr; 20(2):307-12. PubMed ID: 8730222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of buspirone in alcohol dependence: a review.
    Malec TS; Malec EA; Dongier M
    Alcohol Clin Exp Res; 1996 Aug; 20(5):853-8. PubMed ID: 8865960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A placebo-controlled trial of buspirone in anxious inpatient alcoholics.
    Malcolm R; Anton RF; Randall CL; Johnston A; Brady K; Thevos A
    Alcohol Clin Exp Res; 1992 Dec; 16(6):1007-13. PubMed ID: 1335217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of comorbid generalized anxiety in a recently detoxified alcoholic population with a selective serotonergic drug (buspirone).
    Tollefson GD; Montague-Clouse J; Tollefson SL
    J Clin Psychopharmacol; 1992 Feb; 12(1):19-26. PubMed ID: 1552035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Buspirone augmentation of a selective serotonin reuptake inhibitor: efficacy in two depressed patients with comorbid anxiety and type I alcohol dependence.
    Sprenger D
    J Clin Psychopharmacol; 1997 Oct; 17(5):425-6. PubMed ID: 9315996
    [No Abstract]   [Full Text] [Related]  

  • 6. Buspirone treatment of anxious alcoholics. A placebo-controlled trial.
    Kranzler HR; Burleson JA; Del Boca FK; Babor TF; Korner P; Brown J; Bohn MJ
    Arch Gen Psychiatry; 1994 Sep; 51(9):720-31. PubMed ID: 8080349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicentre double-blind comparison of hydroxyzine, buspirone and placebo in patients with generalized anxiety disorder.
    Lader M; Scotto JC
    Psychopharmacology (Berl); 1998 Oct; 139(4):402-6. PubMed ID: 9809861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological treatments for alcoholism: revisiting lithium and considering buspirone.
    Fawcett J; Kravitz HM; McGuire M; Easton M; Ross J; Pisani V; Fogg LF; Clark D; Whitney M; Kravitz G; Javaid J; Teas G
    Alcohol Clin Exp Res; 2000 May; 24(5):666-74. PubMed ID: 10832908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Buspirone in the treatment of alcoholic patients.
    Bruno F
    Psychopathology; 1989; 22 Suppl 1():49-59. PubMed ID: 2657838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of buspirone and its metabolite 1-pyrimidinylpiperazine in the remission of comorbid anxiety with depressive features and alcohol dependency.
    Tollefson GD; Lancaster SP; Montague-Clouse J
    Psychopharmacol Bull; 1991; 27(2):163-70. PubMed ID: 1924664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, placebo-controlled trial of buspirone for the treatment of anxiety in opioid-dependent individuals.
    McRae AL; Sonne SC; Brady KT; Durkalski V; Palesch Y
    Am J Addict; 2004; 13(1):53-63. PubMed ID: 14766438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone.
    Pollack MH; Worthington JJ; Manfro GG; Otto MW; Zucker BG
    J Clin Psychiatry; 1997; 58 Suppl 11():19-23. PubMed ID: 9363044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy and withdrawal of clobazam, lorazepam and buspirone in the treatment of anxiety disorders].
    Lemoine P; Rouillon F; Pouget D
    Encephale; 1996; 22(6):461-7. PubMed ID: 10901839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical potential and possibilities of using buspirone in the treatment of anxiety disorders].
    Dzampaev AT; Suvorova IA; Damulin IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(8):94-104. PubMed ID: 25389538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled comparison of the effects and abrupt discontinuation of buspirone and lorazepam.
    Bourin M; Malinge M
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 Jul; 19(4):567-75. PubMed ID: 8588056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Buspirone and lorazepam in the treatment of generalized anxiety disorder in outpatients.
    Laakmann G; Schüle C; Lorkowski G; Baghai T; Kuhn K; Ehrentraut S
    Psychopharmacology (Berl); 1998 Apr; 136(4):357-66. PubMed ID: 9600581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of buspirone in smoking cessation: a placebo-controlled trial.
    Schneider NG; Olmstead RE; Steinberg C; Sloan K; Daims RM; Brown HV
    Clin Pharmacol Ther; 1996 Nov; 60(5):568-75. PubMed ID: 8941030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation and treatment of anxiety symptoms and disorders in alcoholics.
    Kranzler HR
    J Clin Psychiatry; 1996; 57 Suppl 7():15-21; discussion 22-4. PubMed ID: 8690692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A controlled study of cognitive behaviour therapy with buspirone or placebo in panic disorder with agoraphobia.
    Cottraux J; Note ID; Cungi C; Légeron P; Heim F; Chneiweiss L; Bernard G; Bouvard M
    Br J Psychiatry; 1995 Nov; 167(5):635-41. PubMed ID: 8564320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buspirone in Children and Adolescents with Anxiety: A Review and Bayesian Analysis of Abandoned Randomized Controlled Trials.
    Strawn JR; Mills JA; Cornwall GJ; Mossman SA; Varney ST; Keeshin BR; Croarkin PE
    J Child Adolesc Psychopharmacol; 2018 Feb; 28(1):2-9. PubMed ID: 28846022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.